Document is current
Any future updates will be listed below
-
Authors
Tian, Haiqing
Zhu, Yixuan
Ma, Haozhe
Su, Nan
Zhang, Manli
La, Xiaolin
Cui, Lei
Zhang, Zijian
Dong, Jing
Zhang, Mengjie
-
Funding
Funding for this research was provided by:
Natural Science Foundation of Xinjiang (NO. 2021D01C296)
- License Information
-
More Information
Article History
Received: 10 January 2026
Accepted: 8 July 2026
First Online: 23 July 2026
Declarations
Ethics approval and consent to participate: The studies involving human participants were reviewed and approved by the Ethics Committee of the First Affiliated Hospital of Xinjiang Medical University, China (20230608-2 which was issued on June 12th, 2023).This study was conducted and reported in accordance with the ARRIVE guidelines 2.0. The title of the approved project is “[Treatment of thin endometrium with platelet concentrate products administered into uterine cavity]”.The participants provided their written informed consent to participate in this study. Animal studies were reviewed and approved by the Ethics Committee of the Experimental Animal Centre of Xinjiang Medical University, China (issued number IACUC-JT-20230321-71 on March 21 st, 2023). Title of the approved project: The investigation of injectable platelet rich fibrin (i-PRF) on improving thin endometrium in a rat model.
Consent for publication: Not applicable.
Competing interests: The authors declare no competing interests.
